In one case of invasive urothelial bladder carcinoma, Prado et al. FACS-isolated CD44+/CD49f+/EpCAM+ CSCs from both primary tumor and lymph node metastases and analyzed them by WES, comparing results with the bulk tumor cells and normal lymph nodes [18]. This evidence concerns the gene CD44 and neoplasm.